Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account
Details

Acknowledgment Letter from FDA DMB to Strides Pharma, Inc.

FDA-2026-P-5017-0002Other
Document

Details

The document's own metadata, straight from the source system.

Title
Acknowledgment Letter from FDA DMB to Strides Pharma, Inc.
Posted
May 7, 2026
Agency
Food and Drug Administration (FDA)
View on regulations.gov ↗